Sterol regulation of fatty acid synthase promoter: coordinate feedback regulation of two mayor lipid pathways by Bennett, Mary K. et al.
Sterol Regulation of Fatty Acid Synthase Promoter
COORDINATE FEEDBACK REGULATION OF TWO MAJOR LIPID PATHWAYS*
(Received for publication, June 29, 1995, and in revised form, August 14, 1995)
Mary K. Bennett‡, Jose M. Lopez‡, Hugo B. Sanchez§, and Timothy F. Osborne¶
From the Department of Molecular Biology and Biochemistry, University of California, Irvine,
Irvine, California 92717-3900
The gene encoding fatty acid synthase, the essential
multi-functional enzyme of fatty acid biosynthesis, is
shown to be regulated by cellular sterol levels similar to
genes that encode important proteins of cholesterol me-
tabolism. We show that expression of the endogenous
FAS gene is repressed when regulatory sterols are in-
cluded in the culture medium of HepG2 cells and that
the FAS promoter is subject to similar regulation when
fused to the luciferase reporter gene. Mutational studies
demonstrate that sterol regulation is mediated by bind-
ing sites for the sterol regulatory element-binding pro-
tein (SREBP) and transcription factor Sp1, making it
mechanistically similar to sterol regulation of the low
density lipoprotein receptor gene. It is also demon-
strated that SREBP and Sp1 synergistically activate the
FAS promoter in Drosophila tissue culture cells, which
lack endogenous Sp1. These experiments provide key
molecular evidence that directly links themetabolism of
fatty acids and cholesterol together.
Coordinate regulation of fatty acid and cholesterol accumu-
lation is essential for balanced membrane biosynthesis and
turnover to accommodate metabolic fluctuations that occur
during normal cellular growth. Also, these two important lipids
are simultaneously required in the liver for regular-ordered
assembly of very low density lipoprotein particles, which de-
liver their lipid load of cholesterol and fatty acids from the liver
to other sites in the body to maintain lipid homeostasis (1, 2).
Co-regulation of genes that encode important enzymes of
both fatty acid and cholesterol metabolism would be an ideal
way to coordinate lipid regulation, and recent work has iden-
tified a family of transcriptional regulatory proteins that could
link the two pathways together (3–5). Sterol regulatory ele-
ment-binding proteins 1 and 2 (SREBP 1 and 2)1 are highly
related proteins that bind to the same cis-acting elements in
the LDL receptor and HMG-CoA synthase promoters and acti-
vate expression only when cellular sterol stores are depleted (3,
5, 6). The cDNAs for both were cloned based on amino acid
sequence information obtained from the purified proteins (3, 5).
Independently, the rat equivalent of SREBP-1 was cloned
from an adipocyte cDNA expression library (4). The rat mRNA
was expressed at very high levels in brown fat and was also
abundant in white fat and liver. The rat SREBP-1 mRNA was
also induced during adipocyte differentiation in cell culture, so
it was named the adipocyte determination- and differentiation-
dependent factor 1 (ADD1). These observations suggested that
SREBP-1/ADD1 is a regulator of genes that are important for
lipid accumulation in the adipocyte.
The above studies indicate that the activity of SREBP-1/
ADD1 may provide a direct link between the regulation of
cholesterol and fatty acid metabolism. In the present paper we
demonstrate that expression of the mRNA for fatty acid syn-
thase (FAS), an essential enzyme of fatty acid biosynthesis, is
regulated by sterols in a manner similar to genes that encode
important proteins of cholesterol metabolism. Moreover, in the
region of the FAS promoter that is required for sterol regula-
tion there are two binding sites for SREBP-1. One of them is
located close to a binding site for the generic factor Sp1, and we
show this site is crucial for sterol regulation. The involvement
of SREBP-1 and Sp1 in activation of the FAS promoter is
reminiscent of the LDL receptor promoter where both proteins
are essential for sterol regulation as well. These experiments
provide strong evidence for a direct molecular connection be-
tween the regulation of two different classes of cellular lipids
that are both required for cellular growth and normal lipopro-
tein metabolism.
EXPERIMENTAL PROCEDURES
Cells and Media—CV-1 cells were obtained from Dr. K. Cho (Uni-
versity of California, Irvine). HepG2 cells were obtained from the
ATCC. All cell culture materials were obtained from Life Technologies
Inc. Lipoprotein-deficient serum was prepared by ultracentrifugation
as described (7). Cholesterol and 25-OH cholesterol were purchased
from Steraloids Inc., and stock solutions were dissolved in absolute
ethanol.
Cell Culture—HepG2 cells were plated at 225,000 cells/100-mm dish
on day 0. Two days later the dishes were washed three times with
phosphate-buffered saline and split into two groups. One set of dishes
were refed induced medium (DMEM containing 10% lipoprotein-de-
pleted serum) and one set was fed suppressed medium (same but
containing 10 mg/ml cholesterol and 1 mg/ml 25-OH cholesterol) media.
Following a 24-h incubation the cells were harvested for RNA by
the guanidine lysis procedure, followed by cesium chloride gradient
sedimentation (8).
PCR Cloning of FAS cDNA—cDNA was prepared from HepG2 RNA
with the aid of a kit from Invitrogen. The cDNA was used as a template
with PCR primers designed to two highly conserved regions of the fatty
acid synthase mRNA that were chosen by aligning the rat and chicken
FAS cDNA sequences. The 59 primer (59-GACACAGCCTGCTCCTC(C/
T)AG-39) was designed to hybridized to a 20-base pair region beginning
at nucleotide number 249 of the rat cDNA (where the A of the ATG start
* This work was supported in part by National Institutes of Health
Grant HL48044, American Heart Association Grant 93001330, and a
gift from ICI Pharmaceuticals. The costs of publication of this article
were defrayed in part by the payment of page charges. This article must
therefore be hereby marked “advertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
‡ These two contributed equally to these studies and should be con-
sidered jointly as first author.
§ Recipient of an undergraduate fellowship from the National Insti-
tutes of Health.
¶ Established Investigator of the American Heart Association. To
whom correspondence should be addressed. Fax: 714-824-8551.
1 The abbreviations used are: SREBP, sterol regulatory element-
binding protein; LDL, low density lipoprotein; FAS, fatty acid synthase;
HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A; SRE-1, sterol reg-
ulatory element-1; ADD1, adipocyte determination-and differentiation-
dependent factor 1; bHLHzip, basic helix-loop-helix zipper; PCR, po-
lymerase chain reaction; DMEM, Dulbecco’s modified Eagle’s medium;
CMV, cytomegalovirus.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 270, No. 43, Issue of October 27, pp. 25578–25583, 1995
© 1995 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
25578
This is an Open Access article under the CC BY license.
codon is base number 1). The 39 primer (59-AGCATGCC(C/T)AGCT-
TCATGAACTGCACAGA-39) was designed to hybridize to 29 bases of
the opposite strand beginning at nucleotide number 395. The resulting
147-base pair PCR product was cloned directly into the PCR II vector
(Invitrogen), and the DNA sequence of the entire clone was shown to
encode the correct portion of the human FAS mRNA. The insert was
excised from PCR II and inserted into the EcoRI site of m13mp18. A
clone containing the DNA strand equal to the mRNA was used to
generate a probe for S1 nuclease analysis of FAS mRNA.
S1 Nuclease and Primer Extension Analyses—S1 nuclease mapping
was performed with 10-mg aliquots of total RNA prepared from HepG2
cells that were cultured as described above. The details of the S1
nuclease protocol have been described previously (9, 10). Expression of
HMG-CoA synthase and ribosomal protein S17 were analyzed by a
primer extension assay with aliquots of the same samples used for FAS
RNA analyses. The identity of the primers and the protocol have been
described previously (10).
FAS Promoter Plasmids—The rat FAS promoter FAS(21594) CAT
(11) was a kind gift of Dr. Steve Clarke (then of Colorado State Uni-
versity; present address University of Texas at Austin). The FAS pro-
moter fragment from 21594 to 165 was excised and inserted upstream
of the luciferase gene in pGL2 basic (Promega). To generate 2250,
2150, and 2135 derivatives, PCR primers were designed to hybridize
at the corresponding positions and coupled with the common down-
stream primer at 165. The PCR fragments were re-cloned into the
pGL2 basic vector. To generate plasmids D and E (containing the FAS
sequence from 2150 to 243 or 2150 to 273, respectively, linked to a
generic TATA sequence), the same PCR primer used to generate 2150
was used in combination with a primer designed to hybridize and delete
sequences 39 to position 243 or 273. These fragments were then in-
serted just upstream of a generic TATA box sequence positioned up-
stream of the luciferase coding sequence. This minimal “TATA only”
plasmid has been described previously (12).
Transient DNA Transfections—CV-1 cells were grown in DMEM
containing 10% fetal bovine serum and plated on day 0 in 60-mm dishes
at 125,000 cells/dish. On day 1 the cells were refed the same medium
and transfected by the calcium phosphate co-precipitation method. Pre-
cipitates contained 20 mg each of test plasmid and CMV2 b-galactosid-
ase plus 10 mg of salmon sperm DNA in 2 ml of solution. 0.5 ml were
added to each of four dishes, which were incubated for 12–16 h at 37 °C
and 7% CO2. The dishes were washed three times with phosphate-
buffered saline, and duplicate dishes were refed either induced (DMEM
containing 10% lipoprotein-depleted serum) or suppressed (same but
containing 10 mg/ml cholesterol and 1 mg/ml 25-OH cholesterol) media.
Following a 24-h incubation, the cells were harvested by scrapping, cells
from duplicate dishes were pooled, and extracts were prepared by three
freeze-thaw cycles. For activation studies with overexpressed SREBP-1,
the cDNA sequence encoding amino acids 1–490 of SREBP-1 was cloned
by the polymerase chain reaction from HepG2 cell mRNA as described
previously (12) and inserted downstream from the cytomegalovirus
early promoter in the pCMV5 vector (a gift of Dr. David Russell of
University of Texas Southwestern Medical Center). The indicated
amount of this plasmid was included along with the individual FAS-
luciferase reporter construct and the CMV2 b-galactosidase in the
transfection procedure as described above, except the cells were cul-
tured in DMEM containing 10% fetal bovine serum.
Drosophila SL2 cells were obtained from Dr. Al Courey (UCLA) and
cultured at 25 °C in Shields and Sang Drosophila media (Sigma) con-
taining 10% heat-inactivated fetal bovine serum. They were seeded at
1.2 3 106 cells/60-mm dish and transfected by a standard calcium
phosphate co-precipitation method (13). Plasmid pPACSp1 containing
the Sp1 coding sequence under the control of the Drosophila actin 5C
promoter was also obtained from Al Courey. The SREBP-1 represents
amino acids 1–490 of the full-length protein, and the cloning of
the appropriate Drosophila expression plasmid has been described
previously (12).
Enzyme Assays—Luciferase activities were measured in a luminom-
eter with a luciferin reagent from Promega Biotech. b-Galactosidase
assays were performed by a standard colorimetric procedure with 2-ni-
trophenyl-b-D-galactopyranoside as substrate (14). The ratio of lucifer-
ase activity in relative light units was divided by the b-galactosidase
activity (activity/h) for each extract. The data presented here represent
the data from several independent transfections performed in duplicate
for each plasmid in Figs. 2 and 4 (see figure legends for the number of
individual experiments).
Protein Purification—Sp1 and the recombinant SREBP-1 protein
were purified as described (12). The purity and concentration of the
purified proteins were assessed by SDS-PAGE analysis performed with
marker proteins followed by staining with Coomassie Blue.
DNase I Footprinting—[32P]DNA probes were prepared from the
indicated plasmids, incubated with Sp1, SREBP-1, or both proteins
together and digested with DNase I as described (9, 15).
RESULTS
SREBP-1 was independently identified as a bHLHzip pro-
tein involved in activation of sterol-regulated genes and for
adipocyte cell differentiation. This suggests that it may link the
regulation of sterol and fatty acid metabolism. Therefore, we
are interested in characterizing SREBP target genes that are
critical proteins of sterol and fatty acid metabolism. The sterol-
regulated LDL receptor promoter contains an SRE-1 element,
which binds SREBP and is required for sterol regulation. We
found an identical match to the LDL receptor 10-base pair
SRE-1 in the promoter for rat FAS and we determined that
recombinant SREBP-1 binds avidly to this site (see below). The
mammalian FAS is a multi-functional enzyme, which contains
all of the enzymatic activities required for each cycle of fatty
acid chain elongation in one polypeptide chain (16, 17). The
FAS gene and its promoter have been isolated and partially
characterized previously (18, 19). In addition to the SRE ho-
mology, there are three “E-box” sites in the FAS promoter. The
E-box is a consensus recognition site for the bHLHzip proteins
such as SREBP, and the one at 2500 was identified previously
as a potential target of SREBP-1/ADD1 activation (4).
If SREBP binding to the FAS promoter were physiologically
relevant, then the FAS mRNA should be regulated by sterols in
a manner similar to other SREBP activated promoters such as
those for the LDL receptor and HMG-CoA synthase. Therefore,
we prepared mRNA from human HepG2 cells that were cul-
tured in the presence or absence of regulatory sterols and
analyzed FAS mRNA expression by a S1 nuclease protection
FIG. 1. FAS mRNA expression is regulated by cellular sterol
levels. Total cell RNA was prepared from HepG2 cells cultured in the
presence or absence of regulatory sterols as described under “Experi-
mental Procedures.” Top, 50-mg aliquots of RNA from induced (lane 1)
or suppressed (lane 2) were analyzed for FAS mRNA by an S1 nuclease
assay (9, 10). Probe alone (neg) digested with S1 nuclease is in lane 3.
Middle, 20-mg aliquots of the same RNA as above were used to detect
transcription of ribosomal protein S 17 by a primer extension assay (10).
Bottom, 50-mg aliquots of the same RNA as above were used for HMG-
CoA synthase mRNA detection by a primer extension assay that gen-
erates two 59 ends (10). This experiment is representative of three
separate experiments, and the average -fold regulation value of 3.6-fold
(6 0.3) for FAS was determined by analysis with a Bio-Rad
PhosphorImager.
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assay (Fig. 1, top). The results demonstrated FAS mRNA ex-
pression was higher when cells were cultured in the absence of
regulatory sterols compared to when cells are fed sterols. The
expression of HMG-CoA synthase, an important regulated en-
zyme of cholesterol biosynthesis, was similarly regulated (Fig.
1, bottom); however, expression of the mRNA for the non-sterol-
regulated ribosomal protein S17 was present at equal levels in
both RNA samples (Fig. 1, middle). Therefore, FAS mRNA
expression is regulated by cellular sterol levels similar to that
observed for important genes of cholesterol homeostasis.
Next, the sequence of the rat FAS promoter was fused to the
luciferase reporter gene and analyzed by a standard transient
expression assay for sterol regulation (Fig. 2a). The ratio of
luciferase activity obtained for the wild-type promoter from
transfected cells cultured in the absence and presence of regu-
latory sterols provided a measure of sterol regulation. The
full-length promoter exhibited 2.1-fold higher activity in cells
that were cultured in the absence of lipoproteins. A deletion of
all of the sequence down to 2150 resulted in an increase in the
degree of regulation to 4.8-fold. This magnitude of regulation is
similar to that observed for the endogenous FAS mRNA (Fig. 1)
and for the wild-type HMG-CoA synthase and LDL receptor
promoters (see the legend to Fig. 2). These results indicated the
sequence required for sterol regulation of the FAS promoter is
located within the proximal 150 base pairs of the promoter.
Thus, the E-box consensus sites upstream of 2150 are dispen-
sable for sterol regulation. In addition, the normalized data
(Fig. 2b) show that deletion of all sequence upstream of 2150
does not drastically affect the absolute level of expression.
Similar results were obtained by Moustaid et al. (19). The
sequence remaining in the sterol-regulated 2150 construct
included the SRE-1 element consensus, an Sp1 binding site,
and the remaining proximal E-box motif (Fig. 2a).
Next, we made several more promoter constructs to further
define the sequence elements responsible for sterol regulation.
The most significant ones are shown in Fig. 2. When we deleted
15 bases from the 59 side of the 2150 construct sterol regula-
tion was reduced from 4.8- to 3-fold (plasmid C). This suggests
the SRE-1 site is important for maximal sterol regulation. This
plasmid also exhibited a significant drop in basal promoter
activity (Fig. 2b), suggesting the SRE homology is required for
maximal expression. To evaluate the role of the remaining
E-box site, we constructed two additional plasmids. First, the
sequence from 2150 to 243 was fused to a generic TATA
element to provide a basal promoter. This removed the normal
FAS TATA box region but retained both the proximal E-box
and the SRE-1 element. This plasmid was regulated efficiently
by sterols (Fig. 2, plasmid D). However, when we deleted the
sequence between 275 and 243 from the 39 end of this con-
struct, sterol regulation was totally lost (plasmid E).
To determine if the region of the FAS promoter that was
required for sterol regulation was directly responsive to
SREBP-1, we performed co-transfection studies with plasmid D
or E along with a plasmid that encoded amino acids 1–490 of
the SREBP-1 protein. This portion of SREBP-1 contains all of
the information required for transcriptional activation (6, 12).
The results showed the activity of plasmid D was significantly
stimulated by co-transfected SREBP-1, however, plasmid E
was not stimulated (Fig. 2c). Thus, deletion of the proximal
E-box abolished both sterol regulation and activation by
SREBP-1. Importantly, when the activation of the FAS pro-
moter (plasmid D) by varying amounts of co-transfected
SREBP-1 plasmid was directly compared to activation of the
LDL receptor, a very similar dose response was obtained (Fig.
2d). Taken together, all of the above data indicate that the
E-box region at 260 is critical for sterol regulation and activa-
tion by SREBP-1, the magnitude of sterol regulation and acti-
vation by SREBP-1 are similar to that of the LDL receptor, and
that the SRE-1 element at 2150 is required for maximal reg-
ulation and maximal expression.
A DNA probe end-labeled at 2250 and extending past the
mRNA cap site was used to evaluate SREBP-1 binding in this
region by a DNase I footprinting technique. Recombinant
SREBP-1 protein bound to both the SRE-1 site at 2150 and the
proximal E-box motif (Fig. 3a, lane 2), confirming that
SREBP-1 binds to both sites that are important for sterol
regulation of the FAS promoter. SREBP cannot activate ex-
pression efficiently by itself even when its binding site is pre-
sent in multiple copies (12, 20). In the LDL receptor promoter,
there is an Sp1 site close to the SREBP binding site that is also
important for sterol regulation. Interestingly, we noted a po-
tential Sp1 binding site at 290 of the FAS promoter, which is
close to the proximal SREBP-1 binding site E-box (Figs. 2a and
3b), and we determined that purified Sp1 bound to this site
(Fig. 3a, lane 4). When both SREBP-1 and Sp1 were incubated
with the DNA probe, both binding patterns were observed (Fig.
3a, lane 3). The recognition sites for SREBP-1 and Sp1 that are
included within the footprint regions are indicated on the FAS
promoter sequence in Fig. 3b. Based on these studies, it is
likely that SREBP and Sp1 function together to mediate sterol-
dependent activation of the FAS promoter similar to the LDL
receptor promoter.
To specifically evaluate whether the FAS promoter was di-
rectly activated by SREBP-1 and Sp1 together, we performed
co-transfection studies with SREBP-1 and Sp1 expression plas-
mids in Drosophila SL2 cells. These cells lack endogenous Sp1,
yet they retain all of the accessory regulatory proteins required
to respond to exogenously expressed Sp1 (13). We have used
this system previously to demonstrate that SREBP-1 and Sp1
synergistically activate the LDL receptor promoter (12, 21).
When plasmid D was transfected into SL2 cells alone, a basal
level of promoter activity was observed (Fig. 4, lane 1). The
addition of plasmids that express either Sp1 or SREBP alone
slightly stimulated promoter activity (Fig. 4, lanes 2 and 3).
When both expression constructs were included, the activity of
the FAS promoter was stimulated 35-fold (lane 4). However,
plasmid E, which removes the proximal SREBP binding E-box
site, was not activated (lanes 5–8). These experiments confirm
that SREBP and Sp1 activate the FAS promoter synergistically
and that SREBP-1 and Sp1 are both required for activation.
DISCUSSION
These experiments demonstrate that the gene encoding the
important multi-functional enzyme of fatty acid biosynthesis,
fatty acid synthase, is regulated by cellular sterols in a manner
similar to important genes of cholesterol homeostasis (Fig. 1).
The promoter for the FAS gene contains two recognition sites
for SREBP that are essential for maximal activity and sterol
regulation (Figs. 2–4). One of these important SREBP sites is
close to a binding site for the ubiquitous transcription factor
Sp1. This is similar to the LDL receptor promoter, where it was
previously shown that Sp1 and SREBP are both essential for
sterol regulation and promoter activation (12, 22, 23). The
present studies demonstrate that SREBP and Sp1 synergisti-
cally activate the FAS promoter (Fig. 4) similar to our previous
studies for the LDL receptor promoter (12).
One of the SREBP-1 sites is a classic SRE-1 site, which is
identical to the SREBP-1 site of the human LDL receptor
promoter. The other important SREBP-1 site contains an E-box
motif, which is the typical recognition site for basic helix-loop-
helix proteins like SREBP-1. Kim et al. (24) have shown that
SREBP-1 is a unique bHLHzip protein that can bind to both
SRE sites and a subset of E-box sites. This dual specificity is
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FIG. 2. Regulation of the FAS promoter by sterols and identification of sterol regulatory elements that are activated by SREBP-1.
Panel a, promoter deletion series. A scale for the DNA sequence of the rat FAS promoter is shown at the top (18). Notable sequence features are
diagrammed on the line corresponding to the wild type promoter (construct A). There are three E-box consensus sequence elements (CANNTG),
a 10-base pair exact match to the LDL receptor SRE-1, and an Sp1 site that is discussed in the text. Mutant derivatives were made by PCR-assisted
mutagenesis as described under “Experimental Procedures.” The sequence retained in each is indicated by the thin line. All of the plasmids were
analyzed for sterol regulation by a transient DNA transfection assay (12). -Fold regulation is the ratio of normalized luciferase activity expressed
when transfected cells were cultured in the absence or presence of regulatory sterols. The non-sterol-regulated CMV promoter b-galactosidase
expression construct was included as an internal control for normalization. The wild-type HMG-CoA synthase and LDL receptor promoters were
analyzed similarly, and -fold regulation values for these were 7.9 and 3.7, respectively. The mean -fold regulation value for each plasmid and the
standard error for the indicated number of experiments are presented. Panel b, relative activity of FAS promoter constructs. The normalized
luciferase activity from cells cultured in the absence of regulatory sterols and transfected by the longest FAS-Luc construct analyzed in panel a
was set at 100% and all of the values are plotted relative to this value. Plasmids D and E were compared directly to each other because they are
hybrid promoters containing the FAS sequence fused to a generic TATA box. I and S refer to whether the transfected cells were cultured in the
absence (I) or presence (S) of regulatory sterols prior to harvest as described under “Experimental Procedures.” Panel c, activation of FAS promoter
by co-expressed SREBP-1. CV-1 cells were cultured in DMEM and 10% (v/v) fetal bovine serum and analyzed by a standard transient transfection
assay for luciferase expression from plasmid D or E, except that 50 ng of a CMV promoter-based construct expressing amino acids 1–490 of the
human SREBP-1 protein was included. -Fold activation corresponds to the ratio of normalized activity obtained with SREBP-1 co-transfection
divided by the activity in the absence of co-transfection. In panels b and c, the mean -fold regulation value for each plasmid and the standard error
for four independent experiments is presented. Panel d, activation of FAS promoter by over expression of SREBP-1. HepG2 cells were cultured in
DMEM and 10% (v/v) fetal bovine serum and analyzed by a standard transient transfection assay for luciferase expression from FAS-150 or the
wild-type LDL receptor promoter, except that the SREBP-1 expression plasmid described above was included in increasing concentrations as
indicated on the abscissa. -Fold activation is calculated as above.
Sterol Regulation of Fatty Acid Synthase Promoter 25581
mediated in part by the substitution of a tyrosine residue in a
position that in most other bHLH proteins is occupied by an
arginine.
The experiments reported here provide the first example of a
classic E-box imparting sterol regulation onto a specific pro-
moter. In fact, in the sterol regulatory region of the FAS pro-
moter there is a archetypal SRE-1 element and the E-box,
which both bind SREBP-1. An important question, therefore, is
why the E-box is more important for sterol regulation in the
FAS promoter than the SRE-1 element? The answer to this
question is probably due to some basic properties of the
SREBP-1 protein. SREBP-1 apparently cannot activate expres-
sion by itself (see Fig. 4), even when synthetic promoters are
constructed that contain multiple tandem SRE-1 elements (12,
20). A binding site for a neighboring ubiquitous transcription
factor is required. As mentioned above, this ubiquitous factor is
Sp1 for the LDL receptor and ACC promoters where the two
proteins activate expression synergistically. Since the Sp1 site
is closer to the E-box in the FAS promoter, it would probably be
easier for Sp1 and SREBP-1 to communicate together when
bound at these sites.
Interestingly, Moustaid et al. (19) have identified an insulin-
responsive cis-acting site in the FAS promoter, which is in the
same region as the E-box recognition sequence identified here
as being essential for sterol regulation by SREBP-1. It is pos-
sible that SREBP-1 or another bHLHzip protein is responsible
for the insulin response, and further studies should clarify this
issue.
The involvement of SREBP-1 in the expression of key fatty
acid synthetic enzymes as well as for important proteins of
cholesterol homeostasis would ensure coordinated levels of cho-
lesteryl ester and triglyceride for proper assembly of very low
density lipoprotein particles in the liver (1). The fact that
SREBP-1 was independently identified as a protein expressed
in differentiating adipocytes and involved in sterol regulation
suggested it might perform this bridging function, and the
FIG. 3. Identification of binding
sites for SREBP and Sp1 in the sterol
regulatory region of FAS promoter.
Panel a, DNase I footprint analysis. Puri-
fied recombinant SREBP-1 (amino acids
1–490) or Sp1 purified from HeLa cell
extracts were prepared and used in a
standard DNase I footprint analysis with
a probe labeled on the top strand of the
FAS promoter essentially as described
(12). The amounts of each protein used
are indicated. A chemical DNA sequenc-
ing track specific for “G” residues (28) was
included to position the binding sites on
the promoter. The thick vertical line de-
notes the SREBP binding area, and the
thin line marks the Sp1 binding regions,
respectively. Panel b, DNA sequence of
the top strand of the rat FAS promoter
from 2155 to 243 is shown. The footprint
regions identified in panel a encompass
the sites highlighted here. The SRE-1
consensus site is boxed, the proximal E-
box is underlined, and the Sp1 consensus
site is overlined.
FIG. 4. Activation of FAS promoter by SREBP-1 and Sp1 in
Drosophila SL2 cells. Extracts from cells transfected with the FAS
promoter mutants D (lanes 1–4), and E (lanes 5–8) were prepared and
assayed for luciferase activity. Drosophila expression vectors for
SREBP-1 or Sp1 were included as indicated. DNA transfections and
analyses were described previously (12, 21). The activity obtained when
the reporter plasmid was transfected alone was set at 1.0, and all values
are plotted relative to this value. The mean -fold activation values for
each plasmid and the standard error for three separate experiments are
presented.
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present studies have identified a key target gene to link the two
important lipid pathways together. The co-regulation would
also be important in growth regulation of all mammalian cells
to provide proper amounts of fatty acids and cholesterol for
membrane synthesis and assembly.
Studies in both experimental animals and humans have
demonstrated that the quantity and quality of fatty acids in the
diet have profound effects on very low density lipoprotein se-
cretion, LDL receptor mRNA expression, and plasma choles-
terol concentrations that are seemingly independent of the
amount of cholesterol in the diet (25–27). It will be interesting
to determine if these effects are mediated through alterations
in the activity of SREBP-1 and/or -2.
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